PAG invests Rs 2,000 crore in Optimus Drugs for controlling stake

Exact stake size not revealed, sources put the number at 70%

PAG, an Asia-Pacific focussed investment firm, is picking up a controlling stake in Hyderabad based Optimus Drugs, a statement said. Sources reveal that PAG along with consortium partners CX Partners and Samara Capital have reached an agreement to invest Rs 2,000 crore in Optimus drugs. PAG did not disclose the exact stake size.

A source close to the development revealed that Optimus Drugs, Optimus Pharma (a 100 per cent promoter owned company), Optimus Lifesciences (100 per cent promoter owned company) are part of the transaction. While exact stake size is not disclosed, the source said that PAG and consortium will have